Loading...
Loading...
Among the 10 tracked institutional investors we monitor, BBIO (BRIDGEBIO PHARMA INC) is held with a combined value of $4.11B across 54,886,910 shares. The largest holder is VANGUARD GROUP INC with a position worth $1.29B (0.02% of their portfolio). 2 funds opened new positions in the most recent quarter. 4 funds increased their holdings. 4 funds reduced their position.
Total Institutional Value
$4.11B
Total Shares Held
54,886,910
Institutional Holders
10
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $1.29B | 0.02% | New |
| 2 | BlackRock, Inc. | $1.06B | 0.02% | -2.3% |
| 3 | VIKING GLOBAL INVESTORS LP | $879.42M | 2.46% | -17.7% |
| 4 | STATE STREET CORP | $366.42M | 0.01% | -0.6% |
| 5 | CITADEL ADVISORS LLC | $251.76M | 0.04% | +169.7% |
| 6 | FMR LLC | $174.05M | 0.01% | -1.9% |
| 7 | MILLENNIUM MANAGEMENT LLC | $47.03M | 0.02% | +1631.0% |
| 8 | RENAISSANCE TECHNOLOGIES LLC | $27.16M | 0.04% | New |
| 9 | Bridgewater Associates, LP | $19.27M | 0.09% | +501.0% |
| 10 | Point72 Asset Management, L.P. | $3.51M | 0.00% | +521.1% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of BBIO with a position worth $1.29B, representing 0.02% of their portfolio. In total, 10 institutional investors hold BBIO with a combined value of $4.11B.
In the most recent quarter, 2 funds opened a new position in BBIO. Additionally, 4 increased their holdings and 4 reduced their positions.
Institutional investors hold $4.11B worth of BBIO stock across 10 positions. The largest institutional holder is VANGUARD GROUP INC with $1.29B in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For BBIO, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their BBIO positions.